Differences in Platelet α-granule Release between Normals and Immune Thrombocytopenic Patients and between Young and Old Platelets
Authors:
- 1 January 1998
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 80 (09) , 457-462
Abstract
The risk of serious bleeding in patients with immune thrombocytopenic purpura (ITP) appears to be less than in comparably thrombocytopenic patients with megakaryocytic hypoplasia. It has been proposed that this difference is due to enhanced hemostatic activity of young platelets, which are increased in the circulation during ITP. We examined α-granule release in reticulated platelets (RP), which are thought to be the youngest circulating platelets, and in older non-reticulated platelets (non-RP) in normal human controls and ITP patients. Normal controls had a mean RP of 7%, compared with 42% in ITP patients. The mean concentration of thrombin receptor agonist peptide (TRAP) causing 50% of control RP to express CD62P (EC50) was 0.82 ± 0.08 μM (SEM), significantly higher than the TRAP CD62P EC50 for RP in ITP, 0.57 ± 0.06 uM (p = 0.04). Similarly, the TRAP EC 50 for non-RP in controls, 0.84 ± 0.09 μM, was significantly higher than in ITP, 0.56 ± 0.07 μM (p = 0.03), suggesting that all platelets in ITP have an enhanced α-granule threshold response to TRAP compared with controls, while RP and older platelets within each patient group have similar threshold sensitivities to TRAP. By contrast, high-dose TRAP caused RP to express twice as much mean and total CD62P as non-RP in both ITP patients and controls (p <0.05 for both comparisons). We conclude that compared with controls, all platelets in ITP are primed to undergo α-granule release to TRAP, while in both ITP and controls, the newly circulating, reticulated platelets have the potential to contribute greater amounts of CD62P surface ligand compared with older platelets (non-RP) after stimulation. Both the increased RP% and enhanced platelet response to agonist in ITP may contribute to maintenance of hemostasis despite thrombocytopenia.Keywords
Funding Information
- National Institutes of Health
This publication has 12 references indexed in Scilit:
- Flow Cytometry of Neonatal Platelet RNAJournal of Pediatric Hematology/Oncology, 1996
- Reticulated platelet values in normal and thrombocytopenic neonatesThe Journal of Pediatrics, 1996
- Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylationBiochemical Journal, 1996
- P-selectin induces the expression of tissue factor on monocytes.Proceedings of the National Academy of Sciences, 1994
- Autoimmune Antibody in a Patient with Idiopathic Thrombocytopenic Purpura Reacted to the Platelet Low Molecular Weight Glycoproteins and Activated PlateletsAmerican Journal of Clinical Pathology, 1994
- Determination of the percentage of thiazole orange (TO)‐positive, “reticulated” platelets using autologous erythrocyte TO fluorescence as an internal standardCytometry, 1993
- Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpuraBritish Journal of Haematology, 1993
- The Significance of Platelets with Increased RNA Content (Reticulated Platelets) A Measure of the Rate of ThrombopoiesisAmerican Journal of Clinical Pathology, 1992
- Hemostatic Function, Survival, and Membrane Glycoprotein Changes in Young versus Old Rabbit PlateletsJournal of Clinical Investigation, 1981
- The effect of platelet age on platelet adherence to collagenJournal of Clinical Investigation, 1968